Ann Arbor, MI12 Active Studies

Multiple Sclerosis Clinical Trials in Ann Arbor, MI

Find 12 actively recruiting multiple sclerosis clinical trials in Ann Arbor, MI. Connect with local research sites and explore new treatment options.

12
Active Trials
10
Sponsors
10,927
Enrolling

Recruiting Multiple Sclerosis Studies in Ann Arbor

About Multiple Sclerosis Clinical Trials in Ann Arbor

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 12 multiple sclerosis clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 10,927 participants. Research is being sponsored by National Cancer Institute (NCI), University of Washington, University of Michigan Rogel Cancer Center and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Ann Arbor — FAQ

Are there multiple sclerosis clinical trials in Ann Arbor?

Yes, there are 12 multiple sclerosis clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 12 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 18, 2026 from ClinicalTrials.gov